This page shows the latest biologics news and features for those working in and with pharma, biotech and healthcare.
Novartis is fully committed to collaborating with Roche in offering our proven biologics production capabilities,” said Steffen Lang, head of Novartis technical operations and member of the Novartis executive committee.
The FDA has approved the biologics licence application (BLA) for Xolair(omalizumab) prefilled syringe for self-injection across all approved indications in the US.
The efficacy of Chinese biotech company CanSino Biologics's (CanSinoBio) single-dose COVID-19 vaccine could decrease over time, according to the company’s chief scientific officer Zhu Tao.
Following this, BMS and bluebird re-filed the biologics licence application, saying that the new application provided further details about the chemistry, manufacturing and control (CMC) module of the submission to
Mirikizumab also reduced symptoms in patients who had previously not responded to or stopped responding to biologic and/or Janus Kinase (JAK) inhibitor drugs.
In a statement, AZ said that tezepelumab is the first and only biologic medicine to consistently and significantly reduce AAER in a broad population of severe asthma patients, irrespective of baseline ... The unprecedented results from the NAVIGATOR
More from news
Approximately 21 fully matching, plus 603 partially matching documents found.
Other safety and manufacturing events such as three patient deaths in the high-dose arm of the Audentes’ ASPIRO trial and an FDA refusal to review the biologics licence application for
In 2019, four of the top five prescription expenditures in the US were biologics and accounted for approximately $46 billion in expenditures. ... An estimated 1.2 million US patients could gain access to biologics by 2025 as the result of increasing
In comparison to many small-molecule medicines, biologics are often challenging to develop and costly to produce. ... patient access to more affordable, high-quality, and potentially life- changing biologic treatments.
Peter Howarth (pictured above), Global Clinical Scientific Lead for Biologics at GSK looks at the emerging science behind eosinophils and how it is helping to guide the company’s research and ... decisions. The eosinophils test is now well-established
in the manufacturing of complex biologic therapies, Amgen is leveraging this expertise to meet this growing need.
More from intelligence
Approximately 5 fully matching, plus 87 partially matching documents found.
That included the expansion of the company’s biologics and biomarker functions, as well as the addition of inflammation, oncology and immunology discovery groups.
The latest movers in pharma. Crescendo. Crescendo Biologics has appointed Kenji Hashimoto as its new chief medical officer, who joins Crescendo with over 15 years of experience in oncology and ... Kenji has considerable immuno-oncology expertise and an
Tuna currently serves as chief scientific officer at Adaptate Biotherapeutics, and has over 15 years of experience in biologics drug discovery and development.
Bahija has more than 25 years of international leadership experience within the pharmaceutical industry, and joins Immunocore from AstraZeneca, where she has served as President of MedImmune, its global biologics research ... A champion for science and
Commenting on her appointment, Schuermans said: “Sobi has unique capabilities, a heritage in biologics manufacturing, development and supply, and a very exciting future within the rare disease space.
More from appointments
Approximately 8 fully matching, plus 48 partially matching documents found.
So, those with High Cost biologics are going to have to think carefully about their value proposition.
million[i]) received a biologic therapy in the UK in 2012.
because as generic biologics get approved, use of branded biologics goes down and the arthritis pathway becomes cheaper to run. ... Yet, Gilenya aside, we found the medications trending upward were orally administered, which demonstrates a market
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen. ... Biobetters are enhanced versions of originator biologics, which potentially offer added value to
3. For new entrants in the biologics space, adopting net pricing options is crucial since some US payers are volume sensitive and may prefer an older competitor drug that is clinically
More from PMHub
Approximately 7 fully matching, plus 41 partially matching documents found.
imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...